PYXS logo

Pyxis Oncology (PYXS) Company Overview

Profile

Full Name:

Pyxis Oncology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 8, 2021

Indexes:

Not included

Description:

Pyxis Oncology is a biotechnology company focused on developing innovative cancer therapies. They aim to create targeted treatments that improve patient outcomes by harnessing the body's immune system. Their research includes advanced drug candidates designed to treat various types of cancer effectively.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 20, 24 RBC Capital
Outperform
Dec 20, 24 HC Wainwright & Co.
Buy
Nov 21, 24 William Blair
Market Perform
Nov 21, 24 RBC Capital
Outperform
Nov 21, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Stephens & Co.
Overweight
Sep 19, 24 RBC Capital
Outperform
Aug 16, 24 HC Wainwright & Co.
Buy
Aug 8, 24 Stifel
Buy
May 16, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Pyxis Oncology?
  • Does Pyxis Oncology pay dividends?
  • What sector is Pyxis Oncology in?
  • What industry is Pyxis Oncology in?
  • What country is Pyxis Oncology based in?
  • When did Pyxis Oncology go public?
  • Is Pyxis Oncology in the S&P 500?
  • Is Pyxis Oncology in the NASDAQ 100?
  • Is Pyxis Oncology in the Dow Jones?
  • When was Pyxis Oncology's last earnings report?
  • When does Pyxis Oncology report earnings?
  • Should I buy Pyxis Oncology stock now?

What is the ticker symbol for Pyxis Oncology?

The ticker symbol for Pyxis Oncology is NASDAQ:PYXS

Does Pyxis Oncology pay dividends?

No, Pyxis Oncology does not pay dividends

What sector is Pyxis Oncology in?

Pyxis Oncology is in the Healthcare sector

What industry is Pyxis Oncology in?

Pyxis Oncology is in the Biotechnology industry

What country is Pyxis Oncology based in?

Pyxis Oncology is headquartered in United States

When did Pyxis Oncology go public?

Pyxis Oncology's initial public offering (IPO) was on October 8, 2021

Is Pyxis Oncology in the S&P 500?

No, Pyxis Oncology is not included in the S&P 500 index

Is Pyxis Oncology in the NASDAQ 100?

No, Pyxis Oncology is not included in the NASDAQ 100 index

Is Pyxis Oncology in the Dow Jones?

No, Pyxis Oncology is not included in the Dow Jones index

When was Pyxis Oncology's last earnings report?

Pyxis Oncology's most recent earnings report was on Nov 12, 2024

When does Pyxis Oncology report earnings?

The next expected earnings date for Pyxis Oncology is Mar 21, 2025

Should I buy Pyxis Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions